ArticleBioinformatics (Oxford, England)2026
Clarifying the scope and capabilities of ROTS in differential expression analysis.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryRecently, Anwar et al. introduced a method combining the ROTS reproducibility optimisation procedure with empirical Bayes variance estimation from limma. Here, we clarify several methodological aspects to support accurate interpretation of the results. We emphasise that ROTS is a general reproducibility optimisation framework rather than a single statistical test and demonstrate that benchmarking outcomes in the reported spike-in case studies are highly sensitive to analysis and evaluation choices. Furthermore, our reanalyses of the spike-in datasets do not support the reported conclusions, and we were unable to reproduce the results of the clinical Alzheimer's disease case study. These findings highlight the importance of transparent benchmarking practices and careful interpretation of comparative results. AVAILABILITY AND IMPLEMENTATION: The ROTS package is available through Bioconductor. The reanalyses were performed using the original code, with the minimal additions described in the manuscript.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.